You are here: Industry Insights > lupin

News List

Lupin’s Mandideep Unit II Facility Receives EIR from US FDA expresspharma
April 15, 2020
Pharma major Lupin announced the receipt of the Establishment Inspection Report (EIR) after closure of the US FDA inspection of its Mandideep Unit II facility.
Lupin’s Nagpur Facility Receives EIR from US FDA expresspharma
April 14, 2020
The inspection for the facility was carried out by the US FDA between January 6, 2020 and January 10, 2020.
Lupin’s Aurangabad Facility Receives EIR from US FDA expresspharma
April 06, 2020
The inspection for the facility was carried out between February 10, 2020 and February 14, 2020 and concluded with no observations.
Mylan, Lupin Announce Positive CHMP Opinion for Biosimilar Nepexto americanpharmaceuticalreview
April 01, 2020
Mylan and Lupin announced the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Nepexto® ...
Lupin’s Inhalation Research Center, Florida receives EIR from US FDA expresspharma
March 31, 2020
Pharma major Lupin announced the receipt of the Establishment Inspection Report (EIR) from the US FDA for its Inhalation Research Center located at Coral Springs, Florida.
Lupin appoints Ramesh Swaminathan as Chief Financial Officer and Head Corporate Affairs expresspharma
March 30, 2020
Ramesh will lead Lupin’s Finance, Investor Relations, Strategic Planning, Information Technology, Corporate Communications and Administration functions.
Lupin receives ISRS Certification, 8th Edition expresspharma
March 13, 2020
The certification was received after audits were conducted at four of the company’s manufacturing facilities.
Neopharma snaps up Lupin's sterile injectables business in Japan fiercepharma
August 25, 2019
Neopharma, which has been buying and building plants for several years, is at it again. The United Arab Emirates-based drugmaker is buying a sterile injectables plant and drugs in Japan from India’s Lupin.
Lupin to sell Japanese Injectables business to Neopharma Group expresspharma
August 23, 2019
The transaction is subject to customary closing conditions, has been approved by BoD of Lupin
Lupin to sell Japanese injectable biz to Neopharma group biospectrumasia
August 22, 2019
The transaction is subject to customary closing conditions and has been approved by the Board of Directors of Lupin

Previous page 1 2 3 4 5 6 7 8 9 10 ... 19 20 Next page